Table 4.
HRR indicator | Mean | SD | 10th percentile | 90th percentile | Correlation with HRR CATH rate |
---|---|---|---|---|---|
Measures of intensive treatment | |||||
Risk-adjusted 30-day CATH rate | 46.3% | 9.1% | 34.5% | 58.3% | 1.00 |
Risk-adjusted 30-day PTCA rate | 17.7% | 5.1% | 11.3% | 23.6% | 0.81 |
Risk-adjusted 30-day CABG rate | 13.4% | 2.9% | 10.2% | 16.9% | 0.51 |
Risk-adjusted 12-hour PTCA rate | 2.7% | 2.6% | 0.6% | 5.8% | 0.52 |
Measures of Quality of medical management | |||||
Risk-adjusted β-blocker rate | 45.6% | 9.5% | 34.2% | 58.3% | −0.31 |
Support for intensive treatment | |||||
Cardiovascular Surgeons per 100,000 | 1.06 | 0.27 | 0.70 | 1.40 | 0.33 |
Cath Labs per 10,000 | 2.40 | 0.76 | 1.50 | 3.30 | 0.39 |
Demographic characteristics | |||||
log of resident population | 13.96 | 0.89 | 12.72 | 15.18 | −0.05 |
log of per capita income | 9.55 | 0.20 | 9.31 | 9.85 | 0.02 |
Percent College graduates | 19.3% | 5.5% | 13.1% | 26.6% | −0.05 |
Notes: HRR surgical and medical intensity rates are computed as the risk-adjusted fixed effects from a patient level regression the receipt of CATH or beta-blockers on HRR fixed effects and CCP risk-adjusters. CATH propensity is an empirical measure of patient appropriateness for intensive treatments. We define this measure by using fitted values from a logit model of the receipt of cardiac catheterization on all the CCP risk-adjusters.